Legacy of Success

1984

  • 1985


    Launched its first brand Ulsanic (Sucralfate) 500mg tablet, a product of Chugai Pharma, Japan

  • 1986


    Launched antihypertensive drug, Herbesser (Diltiazem) tablet, a product of Mitsubishi Tanabe, Japan

  • 1987


    Started construction of new manufacturing facility at Multan Road, Lahore

  • 1989


    Started marketing products of Duphar Pharma, Holland

  • 1990


    Commencement of production at new manufacturing facility

  • 1993


    Started local manufacturing of products of Solvay Pharmaceuticals, Germany

  • 1994


    • Became a Public Limited Company
    • Entered in export business
  • 1996


    New Product Launches
    An ACE inhibitor, Tanatril (Imidapril) 10mg tablets, a product of Mitsubishi Tanabe, Japan

  • 1997


    New Product Launches
    An antihistamine drug, Senergy-OD (Loratadine) tablets and oral suspension

  • 1998


    Earned ISO 9001 certification

  • 2000


    New Product Launches
    Introduced recombinant vaccine for the treatment of Hepatitis-B with the brand name Heprovac-B

  • 2001


    New Product Launches
    Obtained manufacturing and marketing rights of novel antihistamine, Kestine (Ebastine) a product of Almirall Prodesfarma, Spain

  • 2002


    New Product Launches
    A rheumatic painkiller drug, Rheuoxib (Celecoxib) Capsules

  • 2003


    • Held its First Annual Sales Conference abroad at Pattaya, Thailand.
    • Received 5th best Annual Report 2002 award from Joint Committee of ICAP and ICMAP.
  • 2004


    New Product Launches

    • An antiulcerant drug, Rabecid (Rabeprazole Sodium) enteric coated tablets
    • An Antihyperlipidemia drug, Lipirex (Atorvastatin) tablets
    • A broad spectrum antibiotic, Termibex (Co-Amoxiclav) tablets and dry suspensions
    • An antihistamine drug, Kestine (Ebastine) in liquid form, a product of Almirall Prodesfarma, Spain
    • An antiulcerant drug, Ulsanic (Sucralfate) suspension, a product of Chugai Pharma, Japan
    • Compiled Bioequivalence assessment of enteric coated aspirin brands (Nu-sales with its brand Loprin) after a single oral dose of 150mg in healthy male adults. Published from France and can be viewed online at akademisyen.com/dergiler/impact.asp
    • Acquired brand Tres Orix Forte from its principal Almirall Prodesfarma, Spain for the territories of Pakistan and Kenya
    • Patent Office, UK grants Highnoon Laboratories Limited, the certificate of patent for its novel research oral rehydration formulation “Peptilose”
  • 2005


    New Product Launches
    A blood anticoagulant drug, Pidogrel (Clopidogrel) and Pidogrel (Clopidogrel + Aspirin) combination tablets

  • 2006


    New Product Launches

    • A painkiller drug, Airtal (Aceclofenac) tablets, a product of Almirall Prodesfarma, Spain
    • A broad spectrum antibiotic, Cyrocin (Ciprofloxacin HCl) tablets
    • A broad spectrum antibiotic, Evacef (Cefadroxil Monohydrate) drops and tablets, a line extension
  • 2007


    New Product Launches

    • A broad spectrum injectable antibiotic, Prepenem (Imipenem+Cilastatin) injections
    • A broad spectrum antibiotic, Oxaquin (Moxifloxacin HCl) tablets
  • 2008


    Commencement of Manufacturing facility/ plant up-gradation

  • 2009


    • Silver Jubilee Celebration year
    • Commenced direct marketing in Vietnam and Sri Lanka
    • Under the umbrella of Corporate Social Responsibility, Highnoon started donating Feripro to Pakistan Thalassemia Welfare Society
    • Signed business partnership agreement with Cipla, India

    New Product Launches

    • An antimalarial drug, Artecxin (Artemether+Lumefantrine) and Artecxin Forte (Artemether+Lumefantrine) tablets
    • A novel gastroprokinetic drug, Cidine (CInitapride) tablets, a product of Almirall Prodesfarma, Spain
    • A broad spectrum antibiotic, Efix (Cefixime) Capsules and dry suspension
    • An Antiasthma & COPD product, Combivair (Budesonide + Formoterol Fumarate) dry powder inhaler capsules, a product of Cipla, India
    • An Antiasthma & COPD product, Tiovair (Tiotropium) dry powder inhaler capsules, a product of Cipla, India
    • An Antiasthma & COPD product, Tiovair F (Tiotropium + Formoterol Fumarate) dry powder inhaler capsules, a product of Cipla, India
  • 2010


    New Product Launches
    A disease modifying agent for Osteoarthritis, Artrodar (Diacerein) Capsule, a product of TRB Chemedica, Switzerland

  • 2011


    • Signed agreement with Acino Pharma, Switzerland, for Oncology products
    • Another UV-Spectrometer (Shimadzo, Japan) was added in the laboratory of Quality Control
    • Provided iPADs to Managers of a team for e-communication with doctors
    • Started Sales Effectiveness Office in major cities of Pakistan i.e., Lahore, Karachi and Rawalpindi
    • Launched, Electronic Territory Management System

    New Product Launches

    • An antimalarial drug, Artecxin (Artemether & Lumefantrine), Artecxin Forte (Artemether & Lumefantrine) dispersible tablets and Artecxin Plus (Artemether & Lumefantrine) tablets
    • An antihypertensive drug, Nebix (Nebivolol) tablets
    • An antidiabetic drug, Tagip (Sitagliptin) tablets and Tagipmet (Sitagliptin + Metformin HCL) tablets
    • An antiasthma drug, Ventomax (Montelukast Sodium) tablets
  • 2012


    • Best Performance Award bestowed to Highnoon Laboratories Limited by Honorable President of Pakistan
    • Upgradation of Product Development Laboratory
    • Upgradation of Hormonal Product Manufacturing Facility
    • Completion of Walk-In Stability Chambers
    • Upgradation of Solid Dosage Area
    • Upgradation of Quality Operations Laboratory and Equipment
    • Completion of dedicated Consumer Health Products Manufacturing Facility
  • 2013


    New Product Launches

    • An antiulcerant drug, Axesom (Esomeperazole) capsules
    • An anticough drug, Prospan (Ivy Extract) Syrup, a product of Engelhard, Germany
  • 2014


    New Product Launches

    • An antiasthma drug, Foracort (Formoterol Fumarate + Budesonide) HFA inhaler, a product of Cipla, India
    • A broad spectrum antibiotic, Cyrocin (Ciprofloxacin) Suspension, a line extension
    • An antihypertensive drug, Misar (Telmisartan) tablets
    • A cardioprotective drug, Myogard (herbal combination) tablets
  • 2015


    New Product Launches

    • A herbal anticolic drug, Bonnisan (herbal extract) syrup, a product of Himalaya, India
    • A BPH drug, Prostam (Tamsulosin) capsules
    • A drug for Uric Acid Disorders, Hiloric (Febuxostat) tablets
    • A herbal drug for Liver Disorders, Liv – 52 (herbal extract) capsules, a product of Himalaya, India
  • 2016


    New Product Launches

    • An oral anti-diabetic medicine, XORMET XR
    • A new product in  respiratory segment, Sprahaler Respules

Up to so on till
2017